CD24 and pancreatic neoplasm: Using the pancreatic cancer cell line PANC-1, it was also found that CD44+CD24+ cells have a higher in vivo tumorigenic potential than cells expressing either marker, which are in turn more tumorigenic than CD44−CD24− cells [150].